European approval for Roche’s tocilizumab for the treatment of giant cell arteritis (GCA)
Roche, a global pioneer in pharmaceuticals and diagnostics company, announced that the European Commission (EC) has approved Actemra/RoActemra (tocilizumab) for the treatment... Read More